_targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy
- PMID: 17560117
- DOI: 10.1016/j.critrevonc.2007.04.010
_targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy
Abstract
Sphingolipids not only function as structural components of cell membranes but also act as signaling molecules to regulate fundamental cellular responses, such as cell death and differentiation, proliferation and certain types of inflammation. Particularly the cellular balance between ceramide and sphingosine 1-phosphate seems to be crucial for a cell's decision to either undergo apoptosis or proliferate, two events which are implicated in tumor development and growth. Whereas ceramide possesses proapoptotic capacity in many cell types, sphingosine 1-phosphate acts as a counterplayer able to induce cell proliferation and protect cells from undergoing apoptosis. Therefore, tipping the balance in favour of ceramide production, i.e. by inhibiting ceramidase or sphingosine kinase activities has potential to support its proapoptotic action and hence represents a promising rational approach to effective cancer therapy. This review highlights most recent data on the regulation of cellular sphingolipid formation and their potential implication in tumor development, and provides perspectives for their use as _targets in molecular intervention therapy.
Similar articles
-
Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.Curr Pharm Des. 2006;12(35):4625-35. doi: 10.2174/138161206779010422. Curr Pharm Des. 2006. PMID: 17168766
-
Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.Prog Lipid Res. 2010 Oct;49(4):316-34. doi: 10.1016/j.plipres.2010.02.004. Epub 2010 Mar 1. Prog Lipid Res. 2010. PMID: 20193711 Review.
-
The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.Comp Biochem Physiol B Biochem Mol Biol. 2012 Sep;163(1):26-36. doi: 10.1016/j.cbpb.2012.05.006. Epub 2012 May 18. Comp Biochem Physiol B Biochem Mol Biol. 2012. PMID: 22613819 Review.
-
Sphingolipid metabolizing enzymes as novel therapeutic _targets.Subcell Biochem. 2008;49:487-522. doi: 10.1007/978-1-4020-8831-5_19. Subcell Biochem. 2008. PMID: 18751924 Review.
-
Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.Prog Lipid Res. 2007 Mar;46(2):126-44. doi: 10.1016/j.plipres.2007.03.001. Epub 2007 Mar 14. Prog Lipid Res. 2007. PMID: 17449104 Review.
Cited by
-
Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma.Neuro Oncol. 2012 Apr;14(4):405-15. doi: 10.1093/neuonc/nos005. Epub 2012 Feb 20. Neuro Oncol. 2012. PMID: 22351749 Free PMC article.
-
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway.Molecules. 2022 Nov 22;27(23):8127. doi: 10.3390/molecules27238127. Molecules. 2022. PMID: 36500220 Free PMC article.
-
Regulation of ceramide biosynthesis by TOR complex 2.Cell Metab. 2008 Feb;7(2):148-58. doi: 10.1016/j.cmet.2007.11.015. Cell Metab. 2008. PMID: 18249174 Free PMC article.
-
A review of ceramide analogs as potential anticancer agents.Future Med Chem. 2013 Aug;5(12):1405-21. doi: 10.4155/fmc.13.107. Future Med Chem. 2013. PMID: 23919551 Free PMC article. Review.
-
Potential role of autophagy induced by FLT3-ITD and acid ceramidase in acute myeloid leukemia chemo-resistance: new insights.Cell Commun Signal. 2022 Oct 31;20(1):172. doi: 10.1186/s12964-022-00956-7. Cell Commun Signal. 2022. PMID: 36316776 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
